Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Platelet-rich Plasma for Eyebrow Hypotrichosis
NCT04018859Phase 2Active, not recruiting
- Sponsor
- Northwestern University
- Start
- Sep 2019
- Primary completion
- May 2027
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 2, randomised trial in Eyebrow hypotrichosis comparing Platelet-Rich Plasma with Placebo (sterile saline) (2 arms). Primary endpoint: Clinical change of eyebrow hypotrichosis at 6 months. Started Sep 2019; status: active, not recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
Eyebrow hypotrichosis
Beyond the preview
Go deeper on NCT04018859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04018859.